{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T11:12:36Z","timestamp":1790507556254,"version":"4.1.0"},"reference-count":60,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["molpharm.aspetjournals.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Pharmacology"],"published-print":{"date-parts":[[2021,3]]},"DOI":"10.1124\/molpharm.120.000173","type":"journal-article","created":{"date-parts":[[2021,1,14]],"date-time":"2021-01-14T15:05:28Z","timestamp":1610636728000},"page":"226-241","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":17,"title":["CRISPR\/Cas9 Genome Editing of the Human Topoisomerase II\u03b1 Intron 19 5\u2032 Splice Site Circumvents Etoposide Resistance in Human Leukemia K562 Cells"],"prefix":"10.1016","volume":"99","author":[{"given":"Victor A.","family":"Hernandez","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessika","family":"Carvajal-Moreno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan L.","family":"Papa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicholas","family":"Shkolnikov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hatice Gulcin","family":"Ozer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jack C.","family":"Yalowich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8034-8741","authenticated-orcid":false,"given":"Terry S.","family":"Elton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1124\/molpharm.120.000173_bib1","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1101\/gad.247361.114","article-title":"Detained introns are a novel, widespread class of post-transcriptionally spliced introns","volume":"29","author":"Boutz","year":"2015","journal-title":"Genes Dev"},{"key":"10.1124\/molpharm.120.000173_bib2","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.semcdb.2019.05.006","article-title":"Metabolic and non-metabolic pathways that control cancer resistance to anthracyclines","volume":"98","author":"Capel\u00f4a","year":"2020","journal-title":"Semin Cell Dev Biol"},{"key":"10.1124\/molpharm.120.000173_bib3","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1146\/annurev-biochem-061809-100002","article-title":"New mechanistic and functional insights into DNA topoisomerases","volume":"82","author":"Chen","year":"2013","journal-title":"Annu Rev Biochem"},{"key":"10.1124\/molpharm.120.000173_bib4","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1101\/gr.162339.113","article-title":"Analysis of off-target effects of CRISPR\/Cas-derived RNA-guided endonucleases and nickases","volume":"24","author":"Cho","year":"2014","journal-title":"Genome Res"},{"key":"10.1124\/molpharm.120.000173_bib5","first-page":"237","article-title":"Differential expression of the globin genes in human leukemia K562(S) cells induced to differentiate by hemin or butyric acid","volume":"41","author":"Cioe","year":"1981","journal-title":"Cancer Res"},{"key":"10.1124\/molpharm.120.000173_bib6","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1126\/science.1231143","article-title":"Multiplex genome engineering using CRISPR\/Cas systems","volume":"339","author":"Cong","year":"2013","journal-title":"Science"},{"key":"10.1124\/molpharm.120.000173_bib7","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.ymeth.2005.07.015","article-title":"Use of minigene systems to dissect alternative splicing elements","volume":"37","author":"Cooper","year":"2005","journal-title":"Methods"},{"key":"10.1124\/molpharm.120.000173_bib8","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1093\/nar\/gkn937","article-title":"The DNA cleavage reaction of topoisomerase II: wolf in sheep\u2019s clothing","volume":"37","author":"Deweese","year":"2009","journal-title":"Nucleic Acids Res"},{"key":"10.1124\/molpharm.120.000173_bib9","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pgen.1005768","article-title":"Prp4 kinase grants the license to splice: control of weak splice sites during spliceosome activation","volume":"12","author":"Eckert","year":"2016","journal-title":"PLoS Genet"},{"key":"10.1124\/molpharm.120.000173_bib10","first-page":"161","article-title":"Effects of DNA topoisomerase II\u03b1 splice variants on acquired drug resistance","volume":"3","author":"Elton","year":"2020","journal-title":"Cancer Drug Resist"},{"issue":"Suppl 24","key":"10.1124\/molpharm.120.000173_bib11","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1186\/s12859-019-3251-1","article-title":"BISR-RNAseq: an efficient and scalable RNAseq analysis workflow with interactive report generation","volume":"20","author":"Gadepalli","year":"2019","journal-title":"BMC Bioinformatics"},{"key":"10.1124\/molpharm.120.000173_bib12","doi-asserted-by":"crossref","first-page":"89","DOI":"10.3389\/fphar.2013.00089","article-title":"Mechanisms regulating resistance to inhibitors of topoisomerase II","volume":"4","author":"Ganapathi","year":"2013","journal-title":"Front Pharmacol"},{"key":"10.1124\/molpharm.120.000173_bib13","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/j.redox.2013.12.020","article-title":"OpenComet: an automated tool for comet assay image analysis","volume":"2","author":"Gyori","year":"2014","journal-title":"Redox Biol"},{"key":"10.1124\/molpharm.120.000173_bib14","first-page":"4962","article-title":"Selective use of an alternative stop codon and polyadenylation signal within intron sequences leads to a truncated topoisomerase II alpha messenger RNA and protein in human HL-60 leukemia cells selected for resistance to mitoxantrone","volume":"55","author":"Harker","year":"1995","journal-title":"Cancer Res"},{"key":"10.1124\/molpharm.120.000173_bib15","doi-asserted-by":"crossref","first-page":"1878","DOI":"10.1128\/MCB.01071-09","article-title":"Competing upstream 5\u2032 splice sites enhance the rate of proximal splicing","volume":"30","author":"Hicks","year":"2010","journal-title":"Mol Cell Biol"},{"key":"10.1124\/molpharm.120.000173_bib16","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1038\/nbt.2647","article-title":"DNA targeting specificity of RNA-guided Cas9 nucleases","volume":"31","author":"Hsu","year":"2013","journal-title":"Nat Biotechnol"},{"key":"10.1124\/molpharm.120.000173_bib17","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.1016\/j.cell.2014.05.010","article-title":"Development and applications of CRISPR-Cas9 for genome engineering","volume":"157","author":"Hsu","year":"2014","journal-title":"Cell"},{"key":"10.1124\/molpharm.120.000173_bib18","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1128\/MCB.06423-11","article-title":"RBFOX2 promotes protein 4.1R exon 16 selection via U1 snRNP recruitment","volume":"32","author":"Huang","year":"2012","journal-title":"Mol Cell Biol"},{"key":"10.1124\/molpharm.120.000173_bib19","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1126\/science.1225829","article-title":"A programmable dual-RNA-guided DNA endonuclease in adaptive bacterial immunity","volume":"337","author":"Jinek","year":"2012","journal-title":"Science"},{"key":"10.1124\/molpharm.120.000173_bib20","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1124\/mol.117.111567","article-title":"The novel C-terminal truncated 90-kDa isoform of topoisomerase II\u03b1 (TOP2\u03b1\/90) is a determinant of etoposide resistance in K562 leukemia cells via heterodimerization with the TOP2\u03b1\/170 isoform","volume":"93","author":"Kanagasabai","year":"2018","journal-title":"Mol Pharmacol"},{"key":"10.1124\/molpharm.120.000173_bib21","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1124\/jpet.116.237107","article-title":"Alternative RNA processing of topoisomerase II\u03b1 in etoposide-resistant human leukemia K562 cells: intron retention results in a novel C-terminal truncated 90-kDa isoform","volume":"360","author":"Kanagasabai","year":"2017","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/molpharm.120.000173_bib22","first-page":"253","article-title":"Immunoblot analysis and band depletion assays","volume":"94","author":"Kaufmann","year":"1999","journal-title":"Methods Mol Biol"},{"key":"10.1124\/molpharm.120.000173_bib23","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1038\/nmeth.3317","article-title":"HISAT: a fast spliced aligner with low memory requirements","volume":"12","author":"Kim","year":"2015","journal-title":"Nat Methods"},{"key":"10.1124\/molpharm.120.000173_bib24","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1101\/gr.171322.113","article-title":"Highly efficient RNA-guided genome editing in human cells via delivery of purified Cas9 ribonucleoproteins","volume":"24","author":"Kim","year":"2014","journal-title":"Genome Res"},{"key":"10.1124\/molpharm.120.000173_bib25","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1242\/jcs.181008","article-title":"Nonsense-mediated mRNA decay in humans at a glance","volume":"129","author":"Kurosaki","year":"2016","journal-title":"J Cell Sci"},{"key":"10.1124\/molpharm.120.000173_bib26","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1093\/nar\/gkx1268","article-title":"Refined sgRNA efficacy prediction improves large- and small-scale CRISPR-Cas9 applications","volume":"46","author":"Labuhn","year":"2018","journal-title":"Nucleic Acids Res"},{"key":"10.1124\/molpharm.120.000173_bib27","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1146\/annurev-biochem-060614-034316","article-title":"Mechanisms and regulation of alternative pre-mRNA splicing","volume":"84","author":"Lee","year":"2015","journal-title":"Annu Rev Biochem"},{"key":"10.1124\/molpharm.120.000173_bib28","doi-asserted-by":"crossref","first-page":"3903","DOI":"10.1091\/mbc.E16-07-0515","article-title":"An NXF1 mRNA with a retained intron is expressed in hippocampal and neocortical neurons and is translated into a protein that functions as an Nxf1 cofactor","volume":"27","author":"Li","year":"2016","journal-title":"Mol Biol Cell"},{"key":"10.1124\/molpharm.120.000173_bib29","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.jbiotec.2016.11.011","article-title":"Enhanced CRISPR\/Cas9-mediated precise genome editing by improved design and delivery of gRNA, Cas9 nuclease, and donor DNA","volume":"241","author":"Liang","year":"2017","journal-title":"J Biotechnol"},{"key":"10.1124\/molpharm.120.000173_bib30","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1093\/bioinformatics\/btt656","article-title":"featureCounts: an efficient general purpose program for assigning sequence reads to genomic features","volume":"30","author":"Liao","year":"2014","journal-title":"Bioinformatics"},{"key":"10.1124\/molpharm.120.000173_bib31","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.mrfmmm.2010.08.008","article-title":"Accumulation of true single strand breaks and AP sites in base excision repair deficient cells","volume":"694","author":"Luke","year":"2010","journal-title":"Mutat Res"},{"key":"10.1124\/molpharm.120.000173_bib32","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1126\/science.1232033","article-title":"RNA-guided human genome engineering via Cas9","volume":"339","author":"Mali","year":"2013","journal-title":"Science"},{"key":"10.1124\/molpharm.120.000173_bib33","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1186\/s13059-017-1184-4","article-title":"IRFinder: assessing the impact of intron retention on mammalian gene expression","volume":"18","author":"Middleton","year":"2017","journal-title":"Genome Biol"},{"key":"10.1124\/molpharm.120.000173_bib34","first-page":"193","article-title":"Heterogeneous expression of DNA topoisomerase II alpha isoforms in tumor cell lines","volume":"9","author":"Mo","year":"1997","journal-title":"Oncol Res"},{"key":"10.1124\/molpharm.120.000173_bib35","first-page":"11497","article-title":"The changing paradigm of intron retention: regulation, ramifications and recipes","volume":"47","author":"Monteuuis","year":"2019","journal-title":"Nucleic Acids Res"},{"key":"10.1124\/molpharm.120.000173_bib36","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1038\/nrc2607","article-title":"Targeting DNA topoisomerase II in cancer chemotherapy","volume":"9","author":"Nitiss","year":"2009","journal-title":"Nat Rev Cancer"},{"key":"10.1124\/molpharm.120.000173_bib37","first-page":"179","article-title":"The comet assay. An overview of techniques","volume":"203","author":"Olive","year":"2002","journal-title":"Methods Mol Biol"},{"key":"10.1124\/molpharm.120.000173_bib38","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1038\/nature17664","article-title":"Efficient introduction of specific homozygous and heterozygous mutations using CRISPR\/Cas9","volume":"533","author":"Paquet","year":"2016","journal-title":"Nature"},{"key":"10.1124\/molpharm.120.000173_bib39","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1038\/nrd3404","article-title":"Interfacial inhibitors: targeting macromolecular complexes","volume":"11","author":"Pommier","year":"2011","journal-title":"Nat Rev Drug Discov"},{"key":"10.1124\/molpharm.120.000173_bib40","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1038\/nrm.2016.111","article-title":"Roles of eukaryotic topoisomerases in transcription, replication and genomic stability","volume":"17","author":"Pommier","year":"2016","journal-title":"Nat Rev Mol Cell Biol"},{"key":"10.1124\/molpharm.120.000173_bib41","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1016\/j.cell.2013.02.022","article-title":"Repurposing CRISPR as an RNA-guided platform for sequence-specific control of gene expression","volume":"152","author":"Qi","year":"2013","journal-title":"Cell"},{"key":"10.1124\/molpharm.120.000173_bib42","doi-asserted-by":"crossref","first-page":"W160","DOI":"10.1093\/nar\/gkw257","article-title":"deepTools2: a next generation web server for deep-sequencing data analysis","volume":"44","author":"Ram\u00edrez","year":"2016","journal-title":"Nucleic Acids Res"},{"key":"10.1124\/molpharm.120.000173_bib43","doi-asserted-by":"crossref","first-page":"e47","DOI":"10.1093\/nar\/gkv007","article-title":"Limma powers differential expression analyses for RNA-sequencing and microarray studies","volume":"43","author":"Ritchie","year":"2015","journal-title":"Nucleic Acids Res"},{"key":"10.1124\/molpharm.120.000173_bib44","doi-asserted-by":"crossref","first-page":"2007","DOI":"10.1016\/0006-2952(93)90643-B","article-title":"Altered gene expression in human leukemia K562 cells selected for resistance to etoposide","volume":"46","author":"Ritke","year":"1993","journal-title":"Biochem Pharmacol"},{"key":"10.1124\/molpharm.120.000173_bib45","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1038\/bjc.1994.131","article-title":"Altered stability of etoposide-induced topoisomerase II-DNA complexes in resistant human leukaemia K562 cells","volume":"69","author":"Ritke","year":"1994","journal-title":"Br J Cancer"},{"key":"10.1124\/molpharm.120.000173_bib46","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1038\/nbt.1754","article-title":"Integrative genomics viewer","volume":"29","author":"Robinson","year":"2011","journal-title":"Nat Biotechnol"},{"key":"10.1124\/molpharm.120.000173_bib47","doi-asserted-by":"crossref","first-page":"5858","DOI":"10.1074\/jbc.273.10.5858","article-title":"DNA double-stranded breaks induce histone H2AX phosphorylation on serine 139","volume":"273","author":"Rogakou","year":"1998","journal-title":"J Biol Chem"},{"key":"10.1124\/molpharm.120.000173_bib48","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1038\/nprot.2008.73","article-title":"Analyzing real-time PCR data by the comparative C(T) method","volume":"3","author":"Schmittgen","year":"2008","journal-title":"Nat Protoc"},{"key":"10.1124\/molpharm.120.000173_bib49","doi-asserted-by":"crossref","first-page":"1483","DOI":"10.1002\/ajmg.a.61216","article-title":"Splice variant in ARX leading to loss of C-terminal region in a boy with intellectual disability and infantile onset developmental and epileptic encephalopathy","volume":"179","author":"Shoubridge","year":"2019","journal-title":"Am J Med Genet A"},{"key":"10.1124\/molpharm.120.000173_bib50","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0124633","article-title":"CCTop: an intuitive, flexible and reliable CRISPR\/Cas9 target prediction tool","volume":"10","author":"Stemmer","year":"2015","journal-title":"PLoS One"},{"key":"10.1124\/molpharm.120.000173_bib51","doi-asserted-by":"crossref","first-page":"11750","DOI":"10.1038\/ncomms11750","article-title":"Internal guide RNA interactions interfere with Cas9-mediated cleavage","volume":"7","author":"Thyme","year":"2016","journal-title":"Nat Commun"},{"key":"10.1124\/molpharm.120.000173_bib52","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0196238","article-title":"Chromatin accessibility is associated with CRISPR-Cas9 efficiency in the zebrafish (Danio rerio)","volume":"13","author":"Uusi-M\u00e4kel\u00e4","year":"2018","journal-title":"PLoS One"},{"key":"10.1124\/molpharm.120.000173_bib53","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.gene.2018.05.095","article-title":"Autoregulation of the human splice factor kinase CLK1 through exon skipping and intron retention","volume":"670","author":"Uzor","year":"2018","journal-title":"Gene"},{"key":"10.1124\/molpharm.120.000173_bib54","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1124\/mol.110.068718","article-title":"Myeloperoxidase-dependent oxidation of etoposide in human myeloid progenitor CD34+ cells","volume":"79","author":"Vlasova","year":"2011","journal-title":"Mol Pharmacol"},{"key":"10.1124\/molpharm.120.000173_bib55","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1038\/s41596-018-0113-7","article-title":"Integrative analysis of pooled CRISPR genetic screens using MAGeCKFlute","volume":"14","author":"Wang","year":"2019","journal-title":"Nat Protoc"},{"key":"10.1124\/molpharm.120.000173_bib56","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/s40164-019-0144-y","article-title":"A novel RNA variant of human concentrative nucleoside transporter 1 (hCNT1) that is a potential cancer biomarker","volume":"8","author":"Wang","year":"2019","journal-title":"Exp Hematol Oncol"},{"key":"10.1124\/molpharm.120.000173_bib57","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1186\/s13059-015-0749-3","article-title":"Regulation of constitutive and alternative mRNA splicing across the human transcriptome by PRPF8 is determined by 5\u2032 splice site strength","volume":"16","author":"Wickramasinghe","year":"2015","journal-title":"Genome Biol"},{"key":"10.1124\/molpharm.120.000173_bib58","doi-asserted-by":"crossref","first-page":"5868","DOI":"10.1021\/bi962400y","article-title":"Two COOH-terminal truncated cytoplasmic forms of topoisomerase II \u03b1 in a VP-16-selected lung cancer cell line result from partial gene deletion and alternative splicing","volume":"36","author":"Yu","year":"1997","journal-title":"Biochemistry"},{"key":"10.1124\/molpharm.120.000173_bib59","doi-asserted-by":"crossref","first-page":"e26","DOI":"10.1093\/nar\/gkx1227","article-title":"CRISPR\/Cas9-mediated modulation of splicing efficiency reveals short splicing isoform of Xist RNA is sufficient to induce X-chromosome inactivation","volume":"46","author":"Yue","year":"2018","journal-title":"Nucleic Acids Res"},{"key":"10.1124\/molpharm.120.000173_bib60","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1101\/gr.234948.118","article-title":"Comprehensive, integrated, and phased whole-genome analysis of the primary ENCODE cell line K562","volume":"29","author":"Zhou","year":"2019","journal-title":"Genome Res"}],"container-title":["Molecular Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0026895X24011246?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0026895X24011246?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1124\/molpharm.120.000173","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,19]],"date-time":"2025-02-19T10:36:52Z","timestamp":1739961412000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0026895X24011246"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3]]},"references-count":60,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2021,3]]}},"alternative-id":["S0026895X24011246"],"URL":"https:\/\/doi.org\/10.1124\/molpharm.120.000173","relation":{},"ISSN":["0026-895X"],"issn-type":[{"value":"0026-895X","type":"print"}],"subject":[],"published":{"date-parts":[[2021,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"CRISPR\/Cas9 Genome Editing of the Human Topoisomerase II\u03b1 Intron 19 5\u2032 Splice Site Circumvents Etoposide Resistance in Human Leukemia K562 Cells","name":"articletitle","label":"Article Title"},{"value":"Molecular Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1124\/molpharm.120.000173","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 by The American Society for Pharmacology and Experimental Therapeutics","name":"copyright","label":"Copyright"}]}}